...
首页> 外文期刊>British Journal of Cancer >GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
【24h】

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

机译:GEIS-21:包括吉西他滨和多西他赛在内的强化化疗的多中心II期研究,用于治疗儿童和成人尤因肉瘤:西班牙肉瘤小组(GEIS)的一份报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background:First Spanish trial of Ewing sarcoma (ES) including adults and children with the aim to test the efficacy of Gemcitabine and Docetaxel (G/D) in newly diagnosed high-risk (HR) patients.
机译:背景:一项涉及成人和儿童的尤因肉瘤(ES)的西班牙首次试验,旨在测试吉西他滨和多西他赛(G / D)在新诊断的高危(HR)患者中的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号